558 related articles for article (PubMed ID: 34209762)
1. Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
Vlachakis D; Papakonstantinou E; Sagar R; Bacopoulou F; Exarchos T; Kourouthanassis P; Karyotis V; Vlamos P; Lyketsos C; Avramopoulos D; Mahairaki V
Cells; 2021 Jun; 10(7):. PubMed ID: 34209762
[TBL] [Abstract][Full Text] [Related]
2. Polygenic risk and hazard scores for Alzheimer's disease prediction.
Leonenko G; Sims R; Shoai M; Frizzati A; Bossù P; Spalletta G; Fox NC; Williams J; ; Hardy J; Escott-Price V
Ann Clin Transl Neurol; 2019 Mar; 6(3):456-465. PubMed ID: 30911569
[TBL] [Abstract][Full Text] [Related]
3. From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.
Harrison JR; Mistry S; Muskett N; Escott-Price V
J Alzheimers Dis; 2020; 74(4):1271-1283. PubMed ID: 32250305
[TBL] [Abstract][Full Text] [Related]
4. Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.
Hermes S; Cady J; Armentrout S; O'Connor J; Holdaway SC; Cruchaga C; Wingo T; Greytak EM;
J Alzheimers Dis; 2024; 99(4):1425-1440. PubMed ID: 38788065
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association of polygenic risk extremes for Alzheimer's disease in the UK Biobank.
Gouveia C; Gibbons E; Dehghani N; Eapen J; Guerreiro R; Bras J
Sci Rep; 2022 May; 12(1):8404. PubMed ID: 35589863
[TBL] [Abstract][Full Text] [Related]
6. Applying polygenic risk score methods to pharmacogenomics GWAS: challenges and opportunities.
Zhai S; Mehrotra DV; Shen J
Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38152980
[TBL] [Abstract][Full Text] [Related]
7. Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in a Chinese Cohort.
Li WW; Wang Z; Fan DY; Shen YY; Chen DW; Li HY; Li L; Yang H; Liu YH; Bu XL; Jin WS; Zeng F; Xu ZQ; Yu JT; Chen LY; Wang YJ
Neurosci Bull; 2020 Jul; 36(7):696-704. PubMed ID: 32072450
[TBL] [Abstract][Full Text] [Related]
8. Polygenic Risk Score in African populations: progress and challenges.
Adam Y; Sadeeq S; Kumuthini J; Ajayi O; Wells G; Solomon R; Ogunlana O; Adetiba E; Iweala E; Brors B; Adebiyi E
F1000Res; 2022; 11():175. PubMed ID: 37273966
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
[No Abstract] [Full Text] [Related]
10. Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease.
Chaudhury S; Patel T; Barber IS; Guetta-Baranes T; Brookes KJ; Chappell S; Turton J; Guerreiro R; Bras J; Hernandez D; Singleton A; Hardy J; Mann D; ; Morgan K
Neurobiol Aging; 2018 Feb; 62():244.e1-244.e8. PubMed ID: 29103623
[TBL] [Abstract][Full Text] [Related]
11. Distribution of 54 polygenic risk scores for common diseases in long lived individuals and their offspring.
Gunn S; Wainberg M; Song Z; Andersen S; Boudreau R; Feitosa MF; Tan Q; Montasser ME; O'Connell JR; Stitziel N; Price N; Perls T; Schork NJ; Sebastiani P
Geroscience; 2022 Apr; 44(2):719-729. PubMed ID: 35119614
[TBL] [Abstract][Full Text] [Related]
12. Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases.
Chasioti D; Yan J; Nho K; Saykin AJ
Trends Genet; 2019 May; 35(5):371-382. PubMed ID: 30922659
[TBL] [Abstract][Full Text] [Related]
13. PRSet: Pathway-based polygenic risk score analyses and software.
Choi SW; García-González J; Ruan Y; Wu HM; Porras C; Johnson J; ; Hoggart CJ; O'Reilly PF
PLoS Genet; 2023 Feb; 19(2):e1010624. PubMed ID: 36749789
[TBL] [Abstract][Full Text] [Related]
14. Leveraging existing GWAS summary data of genetically correlated and uncorrelated traits to improve power for a new GWAS.
Xue H; Wu C; Pan W
Genet Epidemiol; 2020 Oct; 44(7):717-732. PubMed ID: 32677173
[TBL] [Abstract][Full Text] [Related]
15. PUMAS: fine-tuning polygenic risk scores with GWAS summary statistics.
Zhao Z; Yi Y; Song J; Wu Y; Zhong X; Lin Y; Hohman TJ; Fletcher J; Lu Q
Genome Biol; 2021 Sep; 22(1):257. PubMed ID: 34488838
[TBL] [Abstract][Full Text] [Related]
16. Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity.
Clark K; Leung YY; Lee WP; Voight B; Wang LS
J Alzheimers Dis; 2022; 89(1):1-12. PubMed ID: 35848019
[TBL] [Abstract][Full Text] [Related]
17. Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
Schork NJ; Elman JA;
J Alzheimers Dis; 2023; 95(3):915-929. PubMed ID: 37661888
[TBL] [Abstract][Full Text] [Related]
18. Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.
Sariya S; Felsky D; Reyes-Dumeyer D; Lali R; Lantigua RA; Vardarajan B; Jiménez-Velázquez IZ; Haines JL; Shellenberg GD; Pericak-Vance MA; Paré G; Mayeux R; Tosto G
Ann Neurol; 2021 Sep; 90(3):366-376. PubMed ID: 34038570
[TBL] [Abstract][Full Text] [Related]
19. Polygenic mediation analysis of Alzheimer's disease implicated intermediate amyloid imaging phenotypes.
Yingxuan E; Yao X; Liu K; Risacher SL; Saykin AJ; Long Q; Zhao Y; Shen L;
AMIA Annu Symp Proc; 2020; 2020():422-431. PubMed ID: 33936415
[TBL] [Abstract][Full Text] [Related]
20. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
